Why does intensive insulin therapy implemented at the onset of type 1 diabetes not decrease prevalence of diabetic microangiopathy?

Journal Title: Archives of Medical Science - Year 2008, Vol 4, Issue 2

Abstract

Authors and Affiliations

Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Magdalena Trepińska, Bogna Wierusz-Wysocka

Keywords

Related Articles

Prognosis and long-term observation of a group of patients with acute coronary syndromes without ST-elevation (ACS-NSTEMI)

Introduction: The clinical assessment of patients with unstable angina is based not only on clinical symptoms, but also on concomitant diseases. The aim of this study was to investigate the adverse outcome in patients re...

Changing concepts on prostatitis

Comparatively little research has been directed to the pathogenesis and treatment of prostatitis, an infectious, inflammatory disabling condition that can cause considerable pelvic pain, with a range of associated sympto...

Alpha-bungarotoxin (α-Bgtx) and beta-bungarotoxin (β-Bgtx) binding activities in human cadaver brain

Introduction: Using 125Iα-Bgtx as a ligand, postsynaptic cholinergic nicotinic receptors has been identified in species. Presynaptic receptors can be defined as receptors at or near the nerve terminal that can positively...

Download PDF file
  • EP ID EP96708
  • DOI -
  • Views 179
  • Downloads 0

How To Cite

Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Magdalena Trepińska, Bogna Wierusz-Wysocka (2008). Why does intensive insulin therapy implemented at the onset of type 1 diabetes not decrease prevalence of diabetic microangiopathy?. Archives of Medical Science, 4(2), 167-173. https://europub.co.uk/articles/-A-96708